Both in Pharmaceuticals
Lexicon Pharmaceuticals vs Olema Pharmaceuticals
Over the past year LXRX returned +3.8% and OLMA returned −19.3%; their daily moves had a correlation of 0.12.
LXRX +3.8% OLMA −19.3%Growth of $1, one year, split-adjusted
| Metric | LXRX | OLMA |
|---|---|---|
| Price | $1.38 | $6.97 |
| Market cap | $614.0M | $609.9M |
| Today | −6.76% | −4.91% |
| 1 month | −24.2% | −15.7% |
| 6 months | −15.3% | −51.3% |
| Year to date | +20.0% | −72.1% |
| 1 year | +3.8% | −19.3% |
| Revenue growth (YoY) | −97.6% | — |
| Gross margin | 94.4% | — |
| Net margin | −4591.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 14.9× | — |
| Net cash | $139.2M | $458.1M |
| Dividend yield | — | — |
| Volatility (60d) | 53.9% | 60.2% |
| Short % of float | 11.8% | 24.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).